Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...

DexCom (DXCM) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.50 per share a year ago. These figures are ...

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...

Believe me when I say I’ve been waiting nearly three months to say these words: Tracker is back-er. The day that fans of CBS’s hit Justin Hartley series have been waiting for since December ...

This feature allows users to track glucose fluctuations alongside detailed nutrition data, providing a comprehensive approach ...

NYSE GMED opened at $83.99 on Friday. Globus Medical has a fifty-two week low of $49.33 and a fifty-two week high of $94.93. The stock has a market cap of $11.44 billion, a PE ratio of 125.36, a P ...

Get Our Latest Research Report on Globus Medical Globus Medical Stock Up 0.0 % Shares of GMED opened at $84.04 on Friday. The stock has a market cap of $11.44 billion, a price-to-earnings ratio of ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended December 2024. While this widely-known consensus ...